哮喘患者为何易感肺炎:上呼吸道细菌相关因素综述
本综述总结哮喘患者肺炎风险增加的证据,并探讨影响鼻咽部细菌携带的因素。肺炎链球菌是肺炎主要细菌病因,鼻咽部携带是侵袭性疾病的重要步骤。哮喘及其治疗可能通过改变上皮微环境或免疫调节影响携带,进而影响疫苗 efficacy。
要点
- 哮喘与肺炎风险增加相关,但机制尚不明确。
- 肺炎链球菌鼻咽部携带是肺炎发生的重要步骤。
- 哮喘治疗(如吸入糖皮质激素)可能影响鼻咽部细菌携带。
核心结论
- 哮喘患者肺炎风险增加,可能与疾病相关炎症或治疗相关免疫调节改变上皮微环境,影响鼻咽部细菌携带有关。
研究设计与样本
- 综述,总结哮喘患者肺炎风险增加及鼻咽部细菌携带影响因素的证据。
主要发现
- 肺炎链球菌是肺炎主要细菌病因,鼻咽部携带是侵袭性和肺部疾病的重要步骤。
- 疫苗可提供个体保护并预防鼻咽部携带,产生群体免疫。
- 哮喘及其治疗可能通过改变上皮微环境或免疫调节影响细菌携带倾向和密度。
临床怎么用
- 综述提示需关注哮喘患者肺炎风险,并考虑疫苗在该人群中的效果可能受携带因素影响。
局限性
- 原文指出关于哮喘易感肺炎的潜在机制信息有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Asthma and pneumonia are common respiratory conditions globally, affecting individuals of all ages. Streptococcus pneumoniae is the predominant bacterial cause of pneumonia, with nasopharyngeal carriage an important step towards invasive and pulmonary disease. Vaccines provide individual protection, and also prevent nasopharyngeal carriage, providing herd immunity. Asthma is associated with an increased risk of pneumonia, but there is limited information on the underlying mechanism of this predisposition. Both asthma and its treatment may conceivably alter propensity to, and density of, carriage through an altered epithelial microenvironment driven by disease-related inflammation or treatment-related immunomodulation, for example with inhaled corticosteroids. The relative importance of these factors could impact the efficacy of vaccines in this vulnerable patient population. In this review, we summarize the evidence for an increased risk of pneumonia in asthma, and discuss factors affecting nasopharyngeal carriage in the context of current guidelines for pneumococcal vaccination.
引用
- Zaidi SR, Blakey JD. Why are people with asthma susceptible to pneumonia? A review of factors related to upper airway bacteria. Respirology. 2019. PMID: 30887658. doi:10.1111/resp.13528
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。